Cosmetic use of heparan sulphate

US10493012B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10493012-B2
Application numberUS-201515527995-A
CountryUS
Kind codeB2
Filing dateNov 19, 2015
Priority dateNov 19, 2014
Publication dateDec 3, 2019
Grant dateDec 3, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Affinity purification of fibroblast growth factor 2-binding heparan sulphate from porcine mucosa (HS8) is disclosed. Also disclosed is a process for the care of keratinous material(s), comprising the application or administration of HS8, or a composition comprising thereof, to keratinous material(s). The composition may be used to improve the condition of skin, such as smoothing the skin, restoring skin elasticity and firmness, or decreasing or preventing wrinkles, and may be formulated for topical or transdermal administration.

First claim

Opening claim text (preview).

The invention claimed is: 1. A cosmetic process for caring for keratinous material(s), the process comprising application or administration of heparan sulphate HS8, or a composition comprising heparan sulphate HS8, to keratinous material(s), wherein the heparan sulphate HS8 is capable of binding a peptide or polypeptide having, or consisting of, the amino acid sequence YCKNGGF (SEQ ID NO:2) or GHFKDPKRLYCKNGGF (SEQ ID NO:1). 2. The process of claim 1 , wherein the keratinous material(s) is selected from one or more of human skin, hair or nails. 3. The process of claim 1 , wherein heparan sulphate HS8 is used or is present in the composition in a content ranging from 0.0001% to 5% by weight, relative to the total weight of the composition. 4. The process of claim 1 , wherein said process is intended to decrease the signs of ageing of the keratinous material(s). 5. The process of claim 1 , wherein said process is intended to maintain and/or stimulate moisturization and/or combat drying-out of the keratinous material(s). 6. The process of claim 2 , wherein said process is intended to: (i) decrease characteristics of wrinkles, small wrinkles and/or fine lines of the skin; (ii) improve and/or decrease the microrelief of the skin; (iii) smooth the skin; (iv) improve the density of the skin; (v) maintain and /or restore skin elasticity; (vi) maintain and/or restore skin firmness; or (vii) maintain and/or restore the cohesion of skin compartments. 7. A cosmetic method of regulating a skin condition, comprising applying or administering to the skin of a human individual a safe and effective amount of heparan sulphate HS8, or a composition comprising heparan sulphate HS8, wherein the heparan sulphate HS8 is capable of binding a peptide or polypeptide having, or consisting of, the amino acid sequence YCKNGGF (SEQ ID NO:2) or GHFKDPKRLYCKNGGF (SEQ ID NO:1). 8. The cosmetic method of claim 7 wherein the method comprises improving skin appearance and/or feel. 9. The cosmetic method of claim 7 , wherein the method comprises regulating visible and/or tactile discontinuities in skin texture. 10. The process of claim 1 wherein the heparan sulphate HS8 is provided in isolated or substantially purified form. 11. The process of claim 1 wherein following digestion with heparin lyases I, II and Ill and then subjecting the resulting disaccharide fragments to capillary electrophoresis analysis the heparan sulphate HS8 has a disaccharide composition comprising: Disaccharide Normalised weight percentage ΔUA,2S-GlcNS,6S 12.7 ± 3.0 ΔUA,2S-GlcNS  7.2 ± 2.0 ΔUA-GlcNS,6S 15.5 ± 3.0 ΔUA,2S-GlcNAc,6S  6.5 ± 2.0 ΔUA-GlcNS 15.7 ± 3.0 ΔUA,2S-GlcNAc  1.0 ± 0.5 ΔUA-GlcNAc,6S  8.9 ± 3.0 ΔUA-GlcNAc 32.5 ± 3.0.

Assignees

Inventors

Classifications

  • A61K8/73Primary

    Polysaccharides · CPC title

  • Anti-ageing preparations · CPC title

  • General cosmetic use · CPC title

  • Preparations for dry skin · CPC title

  • Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10493012B2 cover?
Affinity purification of fibroblast growth factor 2-binding heparan sulphate from porcine mucosa (HS8) is disclosed. Also disclosed is a process for the care of keratinous material(s), comprising the application or administration of HS8, or a composition comprising thereof, to keratinous material(s). The composition may be used to improve the condition of skin, such as smoothing the skin, resto…
Who is the assignee on this patent?
Agency Science Tech & Res, Oreal
What technology area does this patent fall under?
Primary CPC classification A61K8/73. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).